Stocks · Health care · Surgical & Medical Instruments & Apparatus

InspireMD, Inc.

NSPR Clue Score57
United States Fiscal year ends December CIK 0001433607 Results filed 17 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Shane Thomas Gleason
19 May 2026
Chief Commercial Officer
Sell
22,778
$1.01
$23.01K
Shane Thomas Gleason
2 Feb 2026
Chief Commercial Officer
Sell
2,000
$1.60
$3.21K
Shane Thomas Gleason
2 Feb 2026
Chief Commercial Officer
Sell
2,941
$1.59
$4.68K
Shane Thomas Gleason
30 Jan 2026
Chief Commercial Officer
Sell
2,900
$1.63
$4.73K
Shane Thomas Gleason
29 Jan 2026
Chief Commercial Officer
Sell
5,000
$1.65
$8.25K
Shane Thomas Gleason
28 Jan 2026
Chief Commercial Officer
Sell
12,395
$1.65
$20.46K
Shane Thomas Gleason
27 Jan 2026
Chief Commercial Officer
Sell
4,781
$1.66
$7.96K
Shane Thomas Gleason
22 Jan 2026
Chief Commercial Officer
Sell
8,411
$1.57
$13.24K
Shane Thomas Gleason
21 Jan 2026
Chief Commercial Officer
Sell
17,593
$1.62
$28.55K
Shane Thomas Gleason
20 Jan 2026
Chief Commercial Officer
Sell
2,955
$1.59
$4.71K
Shane Thomas Gleason
16 Jan 2026
Chief Commercial Officer
Sell
2,250
$1.61
$3.63K
Shane Thomas Gleason
15 Jan 2026
Chief Commercial Officer
Sell
2,909
$1.58
$4.59K

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 2,561,423
History held since 15 Jun 2011